Sandostatin lar and Multivitamin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sandostatin lar (octreotide acetate) and Multivitamin (ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e). Common drug interactions include weight decreased among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Sandostatin lar and Multivitamin. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Sandostatin lar?

Sandostatin lar has active ingredients of octreotide acetate. It is often used in acromegaly. eHealthMe is studying from 38,437 Sandostatin lar users. Check the latest studies of Sandostatin lar.

What is Multivitamin?

Multivitamin has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. It is often used in vitamin supplementation. eHealthMe is studying from 83,597 Multivitamin users. Check the latest studies of Multivitamin.

On Jul, 09, 2026

87 people who take Sandostatin lar and Multivitamin together, and have interactions are studied.

Sandostatin lar and Multivitamin drug interactions.

What are the common drug interactions of Sandostatin Lar and Multivitamin, by gender? *:

female:

Weight decreased
Influenza
Malaise (a feeling of general discomfort or uneasiness)
Abdominal pain
Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
Aphonia (inability to produce voice)
Bladder disorder
Cardiomegaly (increased size of heart than normal)
Decreased appetite
Ear pain

male:

Abdominal pain
Asthenia (weakness)
Blood pressure systolic increased
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Food poisoning (poison in food)
Heart rate irregular
Hepatic pain (pain in liver)
Hepatitis (inflammation of the liver)
Hepatomegaly (abnormal enlargement of the liver)
Weight increased

What are the common drug interactions of Sandostatin Lar and Multivitamin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Carcinoid heart disease (heart valve disease)
Cardiac failure congestive
Dyspnoea (difficult or laboured respiration)
Eye inflammation
Fatigue (feeling of tiredness)
Hypotension (abnormally low blood pressure)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)

20-29:

n/a

30-39:

n/a

40-49:

Abdominal pain upper
Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
Aphonia (inability to produce voice)
Bladder disorder
Cardiomegaly (increased size of heart than normal)
Decreased appetite
Dizziness
Ear pain
Fatigue (feeling of tiredness)
Headache (pain in head)

50-59:

Heart rate decreased
Pyrexia (fever)
Dyspnoea (difficult or laboured respiration)
Abdominal pain lower
Abdominal pain upper
Liver disorder (liver diseases)
Pancreatic disorder
Malignant neoplasm progression (cancer tumour came back)
Neoplasm malignant (cancer tumour)
Chills (felling of cold)

60+:

Abdominal pain
Body temperature decreased
Hepatic pain (pain in liver)
Hepatitis (inflammation of the liver)
Hepatomegaly (abnormal enlargement of the liver)
Malignant neoplasm progression (cancer tumour came back)
Metastatic carcinoid tumour (a slow-growing type of neuroendocrine tumour spreads to other body part)
Vomiting
Weight decreased
Weight increased

What are the existing conditions these people have? *

Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 39 people, 44.83%
Metastatic Carcinoid Tumor: 10 people, 11.49%
Carcinoid Tumor: 9 people, 10.34%
Thyroid Diseases: 7 people, 8.05%
Neuroendocrine Tumor: 7 people, 8.05%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 6.90%
Headache (pain in head): 5 people, 5.75%
Dizziness: 5 people, 5.75%
Diarrhea: 5 people, 5.75%

* Approximation only. Some reports may have incomplete information.

Do you take Sandostatin lar and Multivitamin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously